tiprankstipranks
Fusion Antibodies Plc (GB:FAB)
:FAB
UK Market

Fusion Antibodies Plc (FAB) Income Statement

Compare
5 Followers

Fusion Antibodies Plc Income Statement

Last quarter (Q4 2023), Fusion Antibodies Plc's total revenue was £595.00K, a decrease of -74.77% from the same quarter last year. In Q4, Fusion Antibodies Plc's net income was £-869.00K. See Fusion Antibodies Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
£ 1.14M£ 2.90M£ 4.80M£ 4.17M£ 3.90M
Gross Profit
£ -265.00K£ 202.00K£ 1.72M£ 1.31M£ 1.15M
Operating Expenses
£ 2.03M£ 3.04M£ 3.05M£ 2.69M£ 2.27M
Depreciation and Amortization
£ 220.00K£ 372.00K£ 751.00K£ 714.00K£ 622.00K
EBITDA
£ -2.06M£ -2.48M£ -573.00K£ -532.00K£ -431.00K
Operating Income
£ -2.29M£ -2.83M£ -1.33M£ -1.38M£ -1.11M
Other Income/Expenses
£ -1.00K£ -1.00K£ -8.00K£ -15.00K£ -14.00K
Pretax Income
£ -2.29M£ -2.86M£ -1.33M£ -1.26M£ -1.07M
Net Income
£ -2.23M£ -2.60M£ -1.20M£ -2.90M£ -697.00K
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ -0.04£ -0.10£ -0.05£ -0.11£ -0.03
Diluted EPS
£ -0.04£ -0.10£ -0.05£ -0.11£ -0.03
Weighted Average Shares Outstanding
55.56M 26.01M 25.95M 25.46M 22.09M
Weighted Average Shares Outstanding (Diluted)
55.56M 26.01M 25.95M 25.46M 22.09M
Currency in GBP

Fusion Antibodies Plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis